|
Peptide-based slides for improving the diagnostic quality of sputum specimens
|
1R43CA206675-01A1
|
$299,999
|
$299,999
|
DARBY, MARTYN
|
AFFINERGY, LLC
|
|
Develop and Apply a Novel Genome-wide Mendelian Randomization Method to Examine Relationship between Obesity and Lung Cancer
|
1R21CA202529-01
|
$199,967
|
$199,967
|
WANG, TAO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$29,981
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$29,998
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$75,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$561,921
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-17
|
$413,086
|
$136,318
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
5F31CA183493-03
|
$48,576
|
$24,288
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy
|
5R01CA154755-07
|
$442,325
|
$221,163
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-05
|
$439,400
|
$145,002
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers
|
5R01CA192954-03
|
$649,734
|
$649,734
|
SHUTER, JONATHAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Exhaled microRNAs leveraged for lung cancer risk assessment
|
5R21CA192168-03
|
$181,613
|
$181,613
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(PQB4) Age-cancer interplay of genome and epi-genome in human lung
|
5R01CA180126-05
|
$700,211
|
$700,211
|
VIJG, JAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-04
|
$346,525
|
$69,305
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
SMOKEFREE ORDINANCE DATABASE
|
261201600721P
|
$15,750
|
$15,750
|
UNKNOWN, UNKNOWN
|
AMERICAN NONSMOKERS RIGH
|
|
Supplement to Promote Diversity: Looming Vulnerability and Smoking Cessation Attempts
|
3R15CA198838-01S1
|
$30,988
|
$30,988
|
HAAGA, DAVID
|
AMERICAN UNIVERSITY
|
|
Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research
|
5R33CA191110-02
|
$240,355
|
$240,355
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
1U01CA214201-01
|
$480,733
|
$240,367
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
7R01CA187143-03
|
$455,917
|
$455,917
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
ALK causes TGF-beta insensitivity in lung cancer cells
|
1R21CA209007-01
|
$172,369
|
$172,369
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
5K07CA181480-03
|
$127,939
|
$127,939
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$3,540
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$5,127
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$3,566
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$14,998
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$4,027
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$97,594
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Integration of Palliative Care for Cancer Patients on Phase I Trials
|
5R01CA177562-03
|
$1,352,242
|
$1,352,242
|
FERRELL, BETTY
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$8,796
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$8,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$2,618
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$24,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$176,400
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
|
1R44CA213507-01
|
$642,097
|
$642,097
|
PHILIBERT, ROBERT
|
BEHAVIORAL DIAGNOSTICS, INC.
|
|
Hyperpolarized NMR for Studies of Cancer Therapies Targeting the Warburg Effect
|
4R01CA169470-04
|
$361,050
|
$361,050
|
GRANT, AARON
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-02
|
$1,025,393
|
$512,697
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Overcoming resistance to tyrosine kinase inhibitors in lung cancer
|
4R01CA169259-04
|
$361,050
|
$361,050
|
KOBAYASHI, SUSUMU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Emergence of drug resistant mutations in lung cancer
|
5R21CA178301-02
|
$233,611
|
$233,611
|
KOBAYASHI, SUSUMU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
PHASE I SBIR CONTRACT - TOPIC 354 - BIOMARKER STRATEGIES - PD: ANDY KURTZ - CS: KELLY FOWLER -- POP 09/19/2016-06/18/2017
|
261201600006C
|
$223,063
|
$223,063
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES
|
|
Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrations
|
4U01CA177799-04
|
$589,257
|
$294,629
|
ZAMAN, MUHAMMAD
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
4UM1CA164974-05
|
$3,236,402
|
$647,280
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules
|
1R01CA210360-01
|
$676,510
|
$676,510
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Boston University-UCLA Lung Cancer Biomarker Development Lab
|
1U01CA214182-01
|
$565,669
|
$565,669
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$159,565
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$55,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$75,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$906,802
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Pathogenesis of the Hamartoma Syndromes
|
4P01CA120964-10
|
$1,781,629
|
$712,652
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Systemic RNA Delivery to Tumors
|
1R01CA200900-01
|
$644,550
|
$644,550
|
SHI, JINJUN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Center of Excellence for High Throughput Proteogenomic Characterization
|
1U24CA210986-01
|
$1,288,045
|
$425,055
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
Total relevant funding to Lung for this search: $283,755,731
|